5791 - 5800 of 8606 Results
Title
Year
-
OPENTitle: Identification of small molecules that bind to the mitochondrial protein mitoNEETJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 21Start Page: 5350End Page: 5353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219Citation Count: 36
- N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase2016OPENTitle: N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 96Issue #:Start Page: 323End Page: 334Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.10.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5102763Citation Count: 36
- Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures2022OPENTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://escholarship.org/content/qt0qr7v3b7/qt0qr7v3b7.pdfCitation Count: 13
- Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach2022OPENTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 10
- Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice2017OPENTitle: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.28377Best OA location URL: https://doi.org/10.7554/elife.28377Citation Count: 96
-
OPENTitle: Increased 5-hydroxymethylation levels in the sub ventricular zone of the Alzheimer's brainJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 26End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.04.002Best OA location URL: https://doi.org/10.1016/j.nepig.2016.04.002Citation Count: 11
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte ChemiePublisher: WileyVol: 130Issue #: 18Start Page: 4980End Page: 4984Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ange.201710779Best OA location URL: https://doi.org/10.1002/ange.201710779Citation Count: 0
-
OPENTitle: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.58997Best OA location URL: https://doi.org/10.7554/elife.58997Citation Count: 49
-
OPENTitle: Immunosuppressants and risk of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 7Start Page: 870End Page: 875Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.580Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.580Citation Count: 79
- Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study2020OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 59